Trials / Completed
CompletedNCT01977131
Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
Phase 1 Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Wei Yu · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to analyze the safety, pulmonary function, and imaging changes of patients with silicosis treated with autologous bone marrow stromal cells with modification by hepatocyte growth factor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cells |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2013-06-01
- Completion
- 2013-09-01
- First posted
- 2013-11-06
- Last updated
- 2013-11-25
Source: ClinicalTrials.gov record NCT01977131. Inclusion in this directory is not an endorsement.